Effectiveness of an Innovative Program in Primary Care for Vulnerable and Precarious Population With Access Barriers to Healthcare System: PASS de Ville

Overview

Since the end of 2018, the Care and Orientation Center (CASO)of Marseille corridnated by Medecins du Monde has been investigated an innovative program aimed at direct referrals to primary care for vulnerable and precarious population with access barriers to healthcare system (no being coveraged at time of the study).

Patients consulting at the CASO MDM in Marseille are accompanied and were received, free of charge, by primary care professionals (general practitioners, specialists, pharmacy, analysis laboratory, etc).

This is an observational, comparative study, with two arms: the CASO MDM in Marseille for the intervention site and the CASO MDM in Bordeaux for the control site (where the innovative program does not exist).

A total of 610 patients will be included (305 in the innovative group / 305 in the control group).

The main objective is to evaluate the effectiveness of the innovative programm (PASS de ville) compared to the standard of care by assessing the rate of emergency departement visits at one year in each group.

Duration of inclusion: 12 months; Duration of follow-up: 18 months; Total duration of the study: 36 months.

Both quantitative and qualitative analyses will be conducted to address overall outcomes.

Univariate and multivariate analyzes will be performed on the primary outcome as well as the secondary outcomes in order to highlight significant differences between the two groups and to identify predictive factors for improved effectiveness. The analysis will be conducted in accordance with Good Epidemiological Practices, and the final report will be written according to the CONSORT (Consolidated Standards of Reporting Trials) recommendations. An intention to treat analysis will be conducted.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 1, 2022

Arms, Groups and Cohorts

  • the innovative programm (PASS de ville)
    • specific care for precarious people
  • the standard of care

Clinical Trial Outcome Measures

Primary Measures

  • rate of emergency departement visits
    • Time Frame: 12 months

Secondary Measures

  • Mean change from baseline in Quality of life scores on the WHOQOL
    • Time Frame: 18 months
    • WHOQOL scale

Participating in This Clinical Trial

Inclusion Criteria

  • at least 18 years old
  • without health coverage
  • having medical needs
  • not presenting a vital emergency
  • not requiring hospital technical platform
  • having declared to want to stay in the area at least 18 months afetr inclusion in the study
  • having signed the notice of non opposition to the study

Exclusion Criteria

  • less than 18 years old
  • having effective health coverage
  • in a life-saving emergency
  • needing access to the hospital technical platform
  • presenting cognitive impairment that limits comprehension

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Assistance Publique Hopitaux De Marseille
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Jean-Olivier ARNAUD, Study Director, AP-HM
  • Overall Contact(s)
    • Pascal AUQUIER, 33(0)4 91 38 47 44, pascal.auquier@univ-amu.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.